Home » Topics » Regulatory

Regulatory
RSS

DIRECT trial begins for prevention and progression of retinopathy in diabetic patients

Nov. 7, 2000

FDA approves once-daily Videx capsules

Nov. 3, 2000

Use of vasopeptidase inhibitors in angina pectoris claimed by BMS

Nov. 2, 2000

Lanicemine now claimed for treatment of headache

Nov. 2, 2000

Microsponge formulation of 5-FU approved by FDA for actinic keratoses

Oct. 31, 2000

Alza's Caelyx approved in E.U. for advanced ovarian cancer

Oct. 27, 2000

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Oct. 27, 2000

Remicade recommended for approval in Europe for broader application

Oct. 26, 2000

First oral chemotherapy for colorectal cancer recommended for approval in Europe

Oct. 24, 2000

Once-weekly Fosamax approved by FDA

Oct. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...